StonvexLoading…
StonvexCore line items from MCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.08B | $7.72B | $5.83B | $3.82B |
Operating Income | $922.00M | $3.35B | $2.58B | $1.66B |
Net Income | $661.00M | $2.46B | $1.85B | $1.20B |
EPS (Diluted) | $3.73 | $13.67 | $10.26 | $6.66 |
Total Assets | $14.73B | $15.83B | $15.41B | $15.49B |
Total Liabilities | $11.59B | $11.63B | $11.30B | $11.38B |
Cash & Equivalents | $1.47B | $2.38B | $2.18B | $2.17B |
Free Cash Flow OCF − CapEx | $844.00M | $2.58B | $1.80B | $1.14B |
Shares Outstanding | 177.30M | 179.90M | 180.20M | 180.50M |